ADC Therapeutics SA (ADCT) stock analysis

In our weekly check, ADC Therapeutics SA is graded F (A to F). Of 22 checks on debt, profit, cash flow and trend: 5 pass, warnings: 1, red flags: 16.

Sector: Healthcare · Biotechnology

Strengths

• Margins rising

Warning signs

• High debt
• Weak interest cover
• Gross margin falling
• Profits not backed by cash
• Weak revenue growth

Next earnings report: 2026-11-10

Similar companies

DBVT · EPRX · BCYC · IVA · MDWD · BNTC

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-10

Open the full analysis